UBX insider filings

Unity Biotechnology, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-04-03. Screen UBX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for UBX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Unity Biotechnology, Inc.

FiledFormInsiderReported transactionsSource
2025-04-034Nguyen Alexander Hieu — CLO and Head of OpsSale (S): 17,852 @ $1.03EDGAR
2025-04-034Sullivan Lynne Marie — CFO & Head of Corp. Dev.Sale (S): 21,867 @ $1.03EDGAR
2025-04-034Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 96,797 @ $1.03EDGAR
2025-03-314Nguyen Alexander Hieu — CLO and Head of OpsSale (S): 1,954 @ $1.16 · Grant/award (A): 44,000 @ $0 · Grant/award (A): 73,000 (derivative) @ $0EDGAR
2025-03-314Sullivan Lynne Marie — CFO & Head of Corp. Dev.Grant/award (A): 65,000 @ $0 · Grant/award (A): 106,000 (derivative) @ $0EDGAR
2025-03-314Ghosh Anirvan — Chief Executive Officer, DirectorGrant/award (A): 175,000 @ $0 · Grant/award (A): 286,000 (derivative) @ $0EDGAR
2025-03-104Hashad Yehia — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-02-054Sullivan Lynne Marie — CFO & Head of Corp. Dev.Sale (S): 153 @ $2.23EDGAR
2025-02-054Nguyen Alexander Hieu — CLO and Head of OpsSale (S): 164 @ $2.23EDGAR
2025-02-054Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 642 @ $2.23EDGAR
2025-01-234Nguyen Alexander Hieu — CLO and Head of OpsGrant/award (A): 150,000 (derivative) @ $0EDGAR
2025-01-234Sullivan Lynne Marie — CFO & Head of Corp. Dev.Grant/award (A): 150,000 (derivative) @ $0EDGAR
2025-01-234Ghosh Anirvan — Chief Executive Officer, DirectorGrant/award (A): 450,000 (derivative) @ $0EDGAR
2025-01-074Grossi Federico — Chief Medical OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2024-11-064Sullivan Lynne Marie — CFO & Head of Corp. Dev.Sale (S): 136 @ $1.29EDGAR
2024-11-064Nguyen Alexander Hieu — Chief Legal OfficerSale (S): 149 @ $1.29EDGAR
2024-11-064Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 432 @ $1.29EDGAR
2024-08-064Nguyen Alexander Hieu — Chief Legal OfficerSale (S): 154 @ $1.53EDGAR
2024-08-064Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 604 @ $1.53EDGAR
2024-08-064Sullivan Lynne Marie — CFO & Head of Corp. Dev.Sale (S): 139 @ $1.53EDGAR
2024-06-264Nguyen Alexander Hieu — Chief Legal OfficerSale (S): 78 @ $1.40EDGAR
2024-06-264Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 1,214 @ $1.40EDGAR
2024-06-264Sullivan Lynne Marie — CFO & Head of Corp. Dev.Sale (S): 324 @ $1.40EDGAR
2024-06-214Roberts Margo R — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2024-06-214O'Neill Gilmore Neil — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2024-06-214Samar Michael P. — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2024-06-214David Nathaniel E — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2024-06-214Leonard Keith R — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2024-06-214Samuels Camille D — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2024-06-214BERNS PAUL L — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2024-05-034Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 603 @ $1.55EDGAR
2024-03-274Nguyen Alexander Hieu — Chief Legal OfficerGrant/award (A): 20,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-02-054Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 680 @ $1.71EDGAR
2024-01-314Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 1,183 @ $1.71EDGAR
2023-11-034Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 589 @ $1.83EDGAR
2023-10-314Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 1,024 @ $1.90EDGAR
2023-09-154Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 1,246 @ $2.47EDGAR
2023-08-034Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 581 @ $2.94EDGAR
2023-08-014Ghosh Anirvan — Chief Executive OfficerSale (S): 1,020 @ $2.86EDGAR
2023-06-274Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 1,177 @ $3.20EDGAR
2023-06-264O'Neill Gilmore Neil — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2023-06-264Roberts Margo R — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2023-06-264Samar Michael P. — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2023-06-264David Nathaniel E — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2023-06-264Leonard Keith R — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2023-06-264Samuels Camille D — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2023-06-264BERNS PAUL L — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2023-06-154Ghosh Anirvan — Chief Executive Officer, DirectorSale (S): 1,212 @ $3.39EDGAR
2023-05-124Nguyen Alexander Hieu — See RemarksGrant/award (A): 40,000 (derivative) @ $2.77 · Disposition to issuer (D): 2,083 (derivative) @ $0 · Grant/award (A): 2,083 (derivative) @ $0 · Disposition to issuer (D): 18,332 (derivative) @ $0 · Grant/award (A): 18,332 (derivative) @ $0EDGAR
2023-05-124Ghosh Anirvan — Chief Executive Officer, DirectorGrant/award (A): 135,000 (derivative) @ $2.77 · Disposition to issuer (D): 24,999 (derivative) @ $0 · Grant/award (A): 24,999 (derivative) @ $0 · Disposition to issuer (D): 15,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Disposition to issuer (D): 29,000 (derivative) @ $0 · +3 moreEDGAR

Recent 8-K events — Unity Biotechnology, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-09-268-K1.02 — Termination of a Material Definitive Agreement
3.03 — Material Modification to Rights of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2025-09-198-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-07-248-K/A1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2025-07-228-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2025-06-308-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-06-208-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2025-05-058-K?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-04-228-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-04-048-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-03-248-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=UBX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs